PRINCIPAL INVESTIGATOR

Victor Outlaw
victoroutlaw@missouri.edu
Chemistry Building Room 309

For his undergraduate studies, Victor attended the University of Virginia, where he received his B.Sc. In Chemistry. As part of his undergraduate work, Victor synthesized analogs of the signaling molecule sphingosine-1-phosphate in the lab of Tim Macdonald (under the mentorship of Frank Foss, now at the University of Texas at Arlington).

Victor received his Ph.D. in Chemistry from Johns Hopkins University under the mentorship of Craig Townsend. His research focused on the development of small-molecule inhibitors of glycerol-3-phosphate acyltransferase (GPAT) as potential anti-obesity therapeutics. As part of this work, Victor developed new synthetic methodology to access highly-substituted indoles and related heterocyclic scaffolds.

Victor was an NIH Postdoctoral Fellow in the lab of Sam Gellman at the University of Wisconsin, where he developed peptide-lipid conjugates as dual inhibitors of human parainfluenza virus 3 (HPIV3) and respiratory syncytial virus (RSV). During the COVID-19 pandemic, in collaboration with the Moscona and Porotto Labs (Columbia University Medical Center), Victor headed the Gellman Lab’s efforts to develop peptide inhibitors of SARS-CoV-2 infection.

Victor joined the Department of Chemistry at the University of Missouri as an Assistant Professor in August 2021.